LISTSERV at the University of Georgia
Menubar Imagemap
Home Browse Manage Request Manuals Register
Previous messageNext messagePrevious in topicNext in topicPrevious by same authorNext by same authorPrevious page (April 2000, week 3)Back to main SAS-L pageJoin or leave SAS-L (or change settings)ReplyPost a new messageSearchProportional fontNon-proportional font
Date:         Thu, 20 Apr 2000 13:23:03 +0200
Reply-To:     Lex Jansen <f.jansen@ORGANON.OSS.AKZONOBEL.NL>
Sender:       "SAS(r) Discussion" <SAS-L@LISTSERV.UGA.EDU>
From:         Lex Jansen <f.jansen@ORGANON.OSS.AKZONOBEL.NL>
Organization: SURFnet BV
Subject:      Re: 12 pt font size and the FDA

The FDA also writes in their Guidance for Industry (IT 3, page 4):

"This guidance has been prepared by the Center for Drug Evaluation and Research (CDER) in cooperation with the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration. This guidance document represents CDER’s current thinking on regulatory submissions in electronic format. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statute, regulations, or both."

Especially the last sentence is interesting.

When they talk about Times New Roman and 12-point font, they specifically talk about narrative text. So this seems to support what Randy is saying.

Lex Jansen NV Organon

Roland wrote in message <38FB877B.62A7@virgin.net>... >Randy Childs wrote: >> >> Is this truly a REQUIREMENT or is it a PREFERENCE? I have worked on projects >> in which we are creating tables and listings (that will go to the FDA) in an 8 >> pt font. In fact, on one of the projects the client told the FDA that it may >> be necessary to use a font as small as 7 points and the FDA was willing to >> accept this. I would check the regulations. A 12 point font may be necessary >> for the study report, but it may not be a "requirement" for the supporting >> tables and listings. >> >> Randy Childs >> Senior Stat Programmer >> Boston Biostatistics, Inc. > >Check out the FDA guidelines, especially where they say they might >REFUSE an electronic submission if it is illegible. In other words their >operatives with their standard computer screens cannot read it properly >because the writing is too small to read. You need to work out if your >"supporting" tables and listings are exempt. I can't see anything >covering that. > >It's all on their website. > >Roland


Back to: Top of message | Previous page | Main SAS-L page